Abstract
Pain is the new burden of the twenty-first century, raising enormous socio-economic costs to developed and underdeveloped countries. Chronic pain is a central nervous system (CNS) pathology, affecting a large proportion of the population. Morphine and its derivatives are still the golden clinical standards for treating pain although they induce severe side effects. To this day, we still have poor understanding of nociceptive pain and its underlying complex mechanisms; furthermore, novelty in clinical analgesics is lacking.
RNA interference technologies are promising both for pain research and treatment. This genetic approach will likely provide new insights into pain mechanisms and eventually offer nonpharmacological therapeutic approaches. In vivo research is thus crucial to reach this goal. Preclinical studies on rodents are necessary to validate small interfering RNA (siRNA) candidates and to target precise physiological pain modulators. Aiming treatment at the CNS is delicate work, and here we will describe how to perform adequate pain research using siRNA, including siRNA preparation and injection, animal behavioral models, and CNS tissue collection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Behlke, M.A. (2006) Progress towards in vivo use of siRNAs. Mol.Ther. 13, 644.
Amarzguioui, M., Lundberg, P., Cantin, E., Hagstrom, J., Behlke, M.A. and Rossi, J.J. (2006) Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Nat. Protoc. 1, 508.
Kim, D.H., Behlke, M.A., Rose, S.D., Chang, M.S., Choi, S. and Rossi, J.J. (2005) Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23, 222.
Dore-Savard, L., Roussy, G., Dansereau, M.A., Collingwood, M.A., Lennox, K.A, Rose, S.D., et al. (2008) Central delivery of Dicer-substrate siRNA: a direct application for pain research. Mol. Ther. 16, 1331–9.
Henry, J.L., Yashpal, K., Pitcher, G.M. and Coderre, T.J. (1999) Physiological evidence that the ‘interphase’ in the formalin test is due to active inhibition. Pain 82, 57–63.
Luo, M.C., Zhang, D.Q., Ma, S.W., Huang, Y.Y., Shuster, S.J., Porreca, F. and Lai, J. (2005) An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. Mol. Pain 1, 29.
Tominaga, M. and Caterina, M.J. (2004) Thermo-sensation and pain. J. Neurobiol. 61, 3–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Sarret, P., Doré-Savard, L., Beaudet, N. (2010). Direct Application of siRNA for In Vivo Pain Research. In: Min, WP., Ichim, T. (eds) RNA Interference. Methods in Molecular Biology, vol 623. Humana Press. https://doi.org/10.1007/978-1-60761-588-0_25
Download citation
DOI: https://doi.org/10.1007/978-1-60761-588-0_25
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-587-3
Online ISBN: 978-1-60761-588-0
eBook Packages: Springer Protocols